134 related articles for article (PubMed ID: 4750895)
1. Correlation among host immunocompetence and tumor stage, tumor grade and vascular permeation in transitional carcinoma.
Catalona WJ; Chretien PB
J Urol; 1973 Nov; 110(5):526-8. PubMed ID: 4750895
[No Abstract] [Full Text] [Related]
2. Abnormalities of cell-mediated immunocompetence in genitourinary cancer.
Catalona WJ; Chretien PB; Trahan EE
J Urol; 1974 Feb; 111(2):229-32. PubMed ID: 4855735
[No Abstract] [Full Text] [Related]
3. Immunological responsiveness in patients with bladder cancer.
Fahey JL; Brosman S; Dorey F
Cancer Res; 1977 Aug; 37(8 Pt 2):2875-8. PubMed ID: 872117
[TBL] [Abstract][Full Text] [Related]
4. Correlation between tumour stage, tumour grade, and immunocompetence in patients with carcinoma of the bladder and prostate.
Adolphs HD; Steffens L
Eur Urol; 1977; 3(1):23-5. PubMed ID: 837950
[TBL] [Abstract][Full Text] [Related]
5. Immune response in bladder cancer.
Merrin C; Han T
J Urol; 1974 Feb; 111(2):170-2. PubMed ID: 4810757
[No Abstract] [Full Text] [Related]
6. Serum ribonuclease in urologic cancer. Relation to host immunocompetence.
Catalona WJ; Chretien PB; Matthews WJ; Tarpley JL
Urology; 1973 Nov; 2(5):577-81. PubMed ID: 4797457
[No Abstract] [Full Text] [Related]
7. Prognostic value of host immunocompetence in urologic cancer patients.
Catalona WJ; Smolev JK; Harty JI
J Urol; 1975 Dec; 114(6):922-6. PubMed ID: 1195475
[TBL] [Abstract][Full Text] [Related]
8. Transitional cell carcinoma of the kidney 25-year experience.
Rubenstein MA; Walz BJ; Bucy JG
J Urol; 1978 May; 119(5):594-7. PubMed ID: 660726
[TBL] [Abstract][Full Text] [Related]
9. Immunologic reduction of bladder cancer recurrence rate.
Olsson CA; Chute R; Rao CN
J Urol; 1974 Feb; 111(2):173-6. PubMed ID: 4810758
[No Abstract] [Full Text] [Related]
10. Defective monocyte chemotactic response in genitourinary carcinoma.
Brosman S; Hausman MS
Urology; 1974 Aug; 4(2):129-34. PubMed ID: 4851277
[No Abstract] [Full Text] [Related]
11. Simultaneous occurrence of hypernephroma and transitional cell carcinoma with development of transitional cell carcinoma in the opposite kidney: case report.
Gillis DJ; Finnerty P; Maxted WC
J Urol; 1971 Nov; 106(5):646-7. PubMed ID: 5115717
[No Abstract] [Full Text] [Related]
12. Cellular immunity in bladder cancer patients.
Guinan P; McKiel C; Flanagan M; Bhatti R; Pessis D; Ablin RJ
J Urol; 1978 Jun; 119(6):747-9. PubMed ID: 660759
[TBL] [Abstract][Full Text] [Related]
13. [Hypernephroma 8 years after transitional carcinoma of the bladder].
Arango Toro OJ; Perscky Arravanti IM; Tores Falco C; Gelabert i Mas A
Arch Esp Urol; 1985; 38(1):63-4. PubMed ID: 3994427
[No Abstract] [Full Text] [Related]
14. Hematuria and right renal mass in a man with superficial bladder tumors.
Presman D; Pandya KK; Brown NL; Recant WM; Pandya PK
J Urol; 1980 Mar; 123(3):416-21. PubMed ID: 7359647
[No Abstract] [Full Text] [Related]
15. Cellular cytotoxicity in vitro in transitional cell carcinoma of the human urinary bladder: 51Cr-release assay.
Troye M; Perlmann P; Larsson A; Blomgren H; Johansson B
Int J Cancer; 1977 Aug; 20(2):188-98. PubMed ID: 892930
[No Abstract] [Full Text] [Related]
16. Pathological findings after preoperative irradiation for carcinoma of the urinary bladder.
Peeples WJ; El-Mahdi AM; Schellhammer PF; Ladaga L
Radiology; 1979 Aug; 132(2):451-4. PubMed ID: 461807
[TBL] [Abstract][Full Text] [Related]
17. Primary tumors of the renal pelvis and ureter.
Melzer M; Braf Z; Beyar H; Rakowszczyk M
Int Surg; 1972 Sep; 57(9):699-702. PubMed ID: 5071822
[No Abstract] [Full Text] [Related]
18. Cell mediated cytotoxicity against human transitional cell carcinomas of the genitourinary tract.
Hakala TR; Lange PH; Castro A; Elliott A; Fraley EE
Cancer; 1974 Dec; 34(6):1929-34. PubMed ID: 4434325
[No Abstract] [Full Text] [Related]
19. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
Raman JD; Sosa RE; Vaughan ED; Scherr DS
Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
[TBL] [Abstract][Full Text] [Related]
20. [The prognostic value of KI-67 proliferation index in transitional cell carcinoma of renal pelvis and ureter].
Korneev IA
Vopr Onkol; 2005; 51(2):211-5. PubMed ID: 16223003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
